Author:
Romanova T S,Myasnikova T N,Khludova L V,Smirnov V G,Latysheva T V
Abstract
Mechanisms of delayed druginduced allergies (DDIA), individual features of the immune response to the drug, influence of various cofactors (concomitant pathology, viral infection, insolation, etc.) create difficulties in diagnostics of drug allergy (DA). Identification and elimination of a causative drug allows to prevent the development of severe allergic reactions. Verification of DA diagnosis during the survey allows to avoid the unreasonable lifelong ban on application of certain drug, which often leads to decreasing of treatment efficiency and increasing its cost. In vitro diagnostic tests are safe, but laborious and expensive. This article will provide the review of literature, reflecting a modern view on the diagnosis of DDIA.
Reference89 articles.
1. Nigen S, Knowles SR, Shear NH. Drug eruptions: approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol. 2003; 2(3): 278-299.
2. Mayorga C, Sanz ML, Gamboa P, Garcia-Aviles MC, Fernande J, Torres MJ, on behalf of the Spanish Society of Allergy and Clinical Immunology (SEAIC) Immunology and Drug Allergy Committee, In Vitro Methods for Diagnosing Non-immediate Hypersensitivity Reactions to Drugs. J Investig Allergol Clin Immunol. 2013; 23(4): 213-225.
3. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity
4. The lymphocyte transformation test in the diagnosis of drug hypersensitivity